PATENT CLAIM ANALYSIS

Application Number: 15979120
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "252160"]

Abstract:
The invention provides compositions and methods that are effective to improve NO production in vivo and/or to increase NO levels in blood. Such compositions and methods may be useful to improve the effects of PDE 5  inhibitors, for example, on erectile dysfunction or pulmonary hypertension.

Claim (Index 20):
The composition of  claim 15  that comprises piperine, L-citruline, L-arginine, microcrystalline cellulose, silicon dioxide, and magnesium stearate, and a PDE 5  inhibitor.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 93.0
- Lexical Diversity: 1.25641
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11139730', '12096718', '10817312', '15891324', '13848325']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7046839146643649
- 35 USC 102 Novelty (BERT): 0.4964600042422221
- Combined Prediction Score: 0.6838615236221506
- Mean Citation Score: 202.900966
- Max Citation Score: 219.90407
- Similarity Product: 166.92956403189774

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test